BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 24794707)

  • 1. MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.
    Chen C; Liu Y; Rappaport AR; Kitzing T; Schultz N; Zhao Z; Shroff AS; Dickins RA; Vakoc CR; Bradner JE; Stock W; LeBeau MM; Shannon KM; Kogan S; Zuber J; Lowe SW
    Cancer Cell; 2014 May; 25(5):652-65. PubMed ID: 24794707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial haplo-deficient tumor suppression in 7q-deficient myelodysplastic syndrome and acute myeloid leukemia.
    Will B; Steidl U
    Cancer Cell; 2014 May; 25(5):555-7. PubMed ID: 24823633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUX1 is a haploinsufficient tumor suppressor gene on chromosome 7 frequently inactivated in acute myeloid leukemia.
    McNerney ME; Brown CD; Wang X; Bartom ET; Karmakar S; Bandlamudi C; Yu S; Ko J; Sandall BP; Stricker T; Anastasi J; Grossman RL; Cunningham JM; Le Beau MM; White KP
    Blood; 2013 Feb; 121(6):975-83. PubMed ID: 23212519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis.
    Arcipowski KM; Bulic M; Gurbuxani S; Licht JD
    PLoS One; 2016; 11(9):e0162515. PubMed ID: 27610619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unbalanced translocation der(7)t(7q;11q): a new recurrent aberration leading to partial monosomy 7q and trisomy 11q in acute myeloid leukemia.
    Yamamoto K; Yakushijin K; Miyata Y; Matsuoka H; Minami H
    Acta Haematol; 2014; 132(2):244-6. PubMed ID: 24862463
    [No Abstract]   [Full Text] [Related]  

  • 6. The enigma of monosomy 7.
    Inaba T; Honda H; Matsui H
    Blood; 2018 Jun; 131(26):2891-2898. PubMed ID: 29615405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Genetic defects of chromosome 5q and 7q in myeloid neoplasms].
    Hosono N
    Rinsho Ketsueki; 2019; 60(7):800-809. PubMed ID: 31391370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular profiling of AML patients with chromosome 7 or 7q deletions in the context of
    Abbas HA; Ayoub E; Sun H; Kanagal-Shamanna R; Short NJ; Issa G; Yilmaz M; Pierce S; Rivera D; Cham B; Wing S; Li Z; Hammond D; Jabbour E; Borthakur G; Garcia-Manero G; Andreeff M; Daver N; Kadia T; Konopleva M; DiNardo C; Ravandi F
    Leuk Lymphoma; 2022 Dec; 63(13):3105-3116. PubMed ID: 36089905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential regulation of the c-Myc/Lin28 axis discriminates subclasses of rearranged MLL leukemia.
    Chen L; Sun Y; Wang J; Jiang H; Muntean AG
    Oncotarget; 2016 May; 7(18):25208-23. PubMed ID: 27007052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Del(5q) and MLL amplification in homogeneously staining region in acute myeloblastic leukemia: a recurrent cytogenetic association.
    Herry A; Douet-Guilbert N; Guéganic N; Morel F; Le Bris MJ; Berthou C; De Braekeleer M
    Ann Hematol; 2006 Apr; 85(4):244-9. PubMed ID: 16425025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of distinctive long noncoding RNA competitive interactions and a six-methylated-gene prognostic signature in acute myeloid leukemia with -5/del(5q) or -7/del(7q).
    Yin X; Huang S; Xu A; Fan F; Chen L; Sun C; Hu Y
    J Cell Biochem; 2020 Feb; 121(2):1563-1574. PubMed ID: 31535409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical role of Jumonji domain of JMJD1C in MLL-rearranged leukemia.
    Izaguirre-Carbonell J; Christiansen L; Burns R; Schmitz J; Li C; Mokry RL; Bluemn T; Zheng Y; Shen J; Carlson KS; Rao S; Wang D; Zhu N
    Blood Adv; 2019 May; 3(9):1499-1511. PubMed ID: 31076406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel human HALR (MLL3) gene encodes a protein homologous to ALR and to ALL-1 involved in leukemia, and maps to chromosome 7q36 associated with leukemia and developmental defects.
    Tan YC; Chow VT
    Cancer Detect Prev; 2001; 25(5):454-69. PubMed ID: 11718452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies.
    El-Menoufy MAM; Mourad ZI; Farahat NM
    J Egypt Natl Canc Inst; 2018 Dec; 30(4):133-138. PubMed ID: 30472199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletions of chromosome arms 7p and 7q in adult acute myeloid leukemia: a marker chromosome confirmed by array comparative genomic hybridization.
    Woo KS; Kim KE; Kim KH; Kim SH; Park JI; Shaffer LG; Han JY
    Cancer Genet Cytogenet; 2009 Oct; 194(2):71-4. PubMed ID: 19781438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploinsufficiency of del(5q) genes, Egr1 and Apc, cooperate with Tp53 loss to induce acute myeloid leukemia in mice.
    Stoddart A; Fernald AA; Wang J; Davis EM; Karrison T; Anastasi J; Le Beau MM
    Blood; 2014 Feb; 123(7):1069-78. PubMed ID: 24381225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5G2 mutant mice model loss of a commonly deleted segment of chromosome 7q22 in myeloid malignancies.
    Wong JC; Weinfurtner KM; Westover T; Kim J; Lebish EJ; Del Pilar Alzamora M; Huang BJ; Walsh M; Abdelhamed S; Ma J; Klco JM; Shannon K
    Leukemia; 2024 May; 38(5):1182-1186. PubMed ID: 38443608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monosomy 7/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia.
    Eldfors S; Saad J; Ikonen N; Malani D; Vähä-Koskela M; Gjertsen BT; Kontro M; Porkka K; Heckman CA
    Blood Adv; 2024 Apr; 8(7):1621-1633. PubMed ID: 38197948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia.
    Baker A; Gregory GP; Verbrugge I; Kats L; Hilton JJ; Vidacs E; Lee EM; Lock RB; Zuber J; Shortt J; Johnstone RW
    Cancer Res; 2016 Mar; 76(5):1158-69. PubMed ID: 26627013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of CUX1 and chromosome 7 in myeloid malignancies.
    Jotte MRM; McNerney ME
    Curr Opin Hematol; 2022 Mar; 29(2):92-102. PubMed ID: 35084368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.